Bellevue Group’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.7M Buy
+1,163,588
New +$34.9M 0.62% 42

Other funds holding ANRO

Bellevue Group's ANRO Position: Q3 2026 in Review

Bellevue Group opened a new position in Alto Neuroscience (ANRO) in Q3 2026: 1,163,588 shares worth $29.7M. The stake represents 0.62% of the portfolio and ranks #42 among its holdings.

133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Bellevue Group held 1,163,588 shares of Alto Neuroscience worth $29.7M as of Q3 2026.
  • Alto Neuroscience was a new Bellevue Group position in Q3 2026.
  • Alto Neuroscience made up 0.62% of Bellevue Group's portfolio in Q3 2026, its #42 holding.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.